Back to Search
NORMAN JAMES, M.D.
M.D.
Internal Medicine Physician
NPI: 1639236706IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 1975
Research & Publications (20)
Inhibition of tissue factor activity reduces the density of cellular network formation in an in vitro model of angiogenesis.
PMID 12023854·Biochem Soc Trans·2002
8-other
Inequivalent contribution of the five tryptophan residues in the C-lobe of human serum transferrin to the fluorescence increase when iron is released.
PMID 19281173·Biochemistry·2009
8-other
Tactical use of the T area in squash by players of differing standard.
PMID 19551552·J Sports Sci·2009
8-other
The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
PMID 19372577·Mol Cancer Res·2009
7-preclinical
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT.
PMID 19447633·Appl Radiat Isot·2009
5-case
Breast, cervical, and colorectal cancer screening rates amongst female Cambodian, Somali, and Vietnamese immigrants in the USA.
PMID 19682356·Int J Equity Health·2009
8-other
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].
PMID 19367257·Mol Ther·2009
3-trial
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.
PMID 19519885·Trials·2009
4-observational
Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer.
PMID 19619056·Hum Gene Ther·2009
3-trial
Structural and functional consequences of the substitution of glycine 65 with arginine in the N-lobe of human transferrin.
PMID 19219998·Biochemistry·2009
8-other
Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney.
PMID 19209019·Onkologie·2009
5-case
In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
PMID 19188160·Clin Cancer Res·2009
7-preclinical
Incorporation of 5-hydroxytryptophan into transferrin and its receptor allows assignment of the pH induced changes in intrinsic fluorescence when iron is released.
PMID 19103311·Biochim Biophys Acta·2009
8-other
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.
PMID 18990168·BJU Int·2009
3-trial
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
PMID 19042080·Eur Urol·2009
3-trial
Synthesis and characterization of iodinated polyurethane with inherent radiopacity.
PMID 19596151·Biomaterials·2009
7-preclinical
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial.
PMID 18760574·Clin Oncol (R Coll Radiol)·2008
8-other
Guillain-Barré Syndrome presenting with bilateral facial nerve paralysis: a case report.
PMID 19063750·Cases J·2008
8-other
Flucloxacillin reduces stiffness following flexor tendon repair.
PMID 18780024·Hand (N Y)·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 443 E 31ST ST
CHICAGO, IL 60616 - Phone
- (312) 225-2055
Quick Facts
- NPI
- 1639236706
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile